{"id":4388,"date":"2021-10-05T18:39:23","date_gmt":"2021-10-05T17:39:23","guid":{"rendered":"https:\/\/ibb.uab.cat\/?p=4388"},"modified":"2021-10-05T19:00:25","modified_gmt":"2021-10-05T18:00:25","slug":"research-advances-in-a-treatment-for-multiple-system-atrophy","status":"publish","type":"post","link":"https:\/\/ibb.uab.cat\/index.php\/2021\/10\/05\/research-advances-in-a-treatment-for-multiple-system-atrophy\/","title":{"rendered":"Research advances in a treatment for multiple system atrophy"},"content":{"rendered":"\n

<\/p>\n\n\n\n

An IBB project led by Salvador Ventura has been one of six selected by the Multiple System Atrophy Coalition in its research grant programme. The grant will allow researchers to advance in the study of molecules they have identified as being potential candidates for a treatment of multiple system atrophy. This neurodegenerative disease affects more than 30,000 people in Europe<\/strong>. <\/p>\n\n\n\n

The Protein Folding and Conformational Diseases research group at the Institute of Biotechnology and Biomedicine (IBB), led by Salvador Ventura, professor of the Department of Biochemistry and Molecular Biology, has won one of the grants awarded annually by the Multiple System Atrophy Coalition, a prestigious international non-profit organisation that aims to improve the quality of life of people with multiple system atrophy (MSA), which affects more than 30,000 people in Europe alone.  <\/p>\n\n\n\n